ATE460421T1 - Phosphinsäurederivate - Google Patents

Phosphinsäurederivate

Info

Publication number
ATE460421T1
ATE460421T1 AT04819605T AT04819605T ATE460421T1 AT E460421 T1 ATE460421 T1 AT E460421T1 AT 04819605 T AT04819605 T AT 04819605T AT 04819605 T AT04819605 T AT 04819605T AT E460421 T1 ATE460421 T1 AT E460421T1
Authority
AT
Austria
Prior art keywords
acid derivatives
phosphinic acid
pharmaceuticals
preparation
pharmaceutical compositions
Prior art date
Application number
AT04819605T
Other languages
English (en)
Inventor
Wolfgang Froestl
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE460421T1 publication Critical patent/ATE460421T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Feed For Specific Animals (AREA)
AT04819605T 2003-11-21 2004-11-19 Phosphinsäurederivate ATE460421T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0327186.3A GB0327186D0 (en) 2003-11-21 2003-11-21 Organic compounds
PCT/EP2004/013177 WO2005054259A1 (en) 2003-11-21 2004-11-19 Phosphinic acid derivatives

Publications (1)

Publication Number Publication Date
ATE460421T1 true ATE460421T1 (de) 2010-03-15

Family

ID=29764265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04819605T ATE460421T1 (de) 2003-11-21 2004-11-19 Phosphinsäurederivate

Country Status (17)

Country Link
US (1) US7498319B2 (de)
EP (1) EP1687319B1 (de)
JP (1) JP4478156B2 (de)
KR (1) KR100807894B1 (de)
CN (1) CN1882598B (de)
AT (1) ATE460421T1 (de)
AU (1) AU2004295060B2 (de)
BR (1) BRPI0416226A (de)
CA (1) CA2545589C (de)
DE (1) DE602004025965D1 (de)
ES (1) ES2341254T3 (de)
GB (1) GB0327186D0 (de)
MX (1) MXPA06005704A (de)
PL (1) PL1687319T3 (de)
PT (1) PT1687319E (de)
RU (1) RU2368616C2 (de)
WO (1) WO2005054259A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109125331A (zh) * 2018-09-13 2019-01-04 大连医科大学附属第二医院 Gabab受体拮抗剂在阻断trek-1通道方面的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
IL114631A (en) * 1990-06-22 1998-12-06 Novartis Ag Anti-epileptic compositions containing gabab- antagonistic compounds
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use

Also Published As

Publication number Publication date
CA2545589A1 (en) 2005-06-16
US20070259835A1 (en) 2007-11-08
RU2368616C2 (ru) 2009-09-27
CN1882598A (zh) 2006-12-20
ES2341254T3 (es) 2010-06-17
PT1687319E (pt) 2010-06-04
EP1687319A1 (de) 2006-08-09
CA2545589C (en) 2013-03-12
EP1687319B1 (de) 2010-03-10
RU2006121648A (ru) 2008-01-10
BRPI0416226A (pt) 2007-01-02
GB0327186D0 (en) 2003-12-24
CN1882598B (zh) 2010-06-16
AU2004295060A1 (en) 2005-06-16
KR100807894B1 (ko) 2008-02-27
US7498319B2 (en) 2009-03-03
PL1687319T3 (pl) 2010-08-31
KR20060097037A (ko) 2006-09-13
AU2004295060B2 (en) 2007-08-30
MXPA06005704A (es) 2006-08-17
JP2007513088A (ja) 2007-05-24
JP4478156B2 (ja) 2010-06-09
DE602004025965D1 (en) 2010-04-22
WO2005054259A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
SE0301653D0 (sv) Novel compounds
SE0301010D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
ATE362932T1 (de) Azaindolverbindungen als kinaseinhibitoren
SE0101675D0 (sv) Novel composition
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
JO2515B1 (en) Gamma-Crystalline form of ivabradine hydrochloride,a process for its preparation and pharmaceutical composition containing it
CY1112721T1 (el) Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
TW200732323A (en) Organic compounds
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
NO20063062L (no) Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
TW200716568A (en) 1H-quinazoline-2,4-diones
MX2009000768A (es) Lactamas macrociclicas.
EA200702375A1 (ru) Производные мочевины, способы их получения и применения
SE0303280D0 (sv) Novel compounds
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
SE0300457D0 (sv) Novel compounds
EA200800393A1 (ru) Новые соединения-аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1687319

Country of ref document: EP